Some OPAL libraries remain closed or are operating at reduced service levels. Materials from those libraries may not be requestable; requested items may take longer to arrive. Note that pickup procedures may differ between libraries. Please contact your library
for new procedures, specific requests, or other assistance.
LEADER 00000cam 2200733Ki 4500
006 m o d
007 cr cnu|||unuuu
008 150121s2015 enk o 000 0 eng d
020 9780191003721|q(electronic bk.)
020 0191003727|q(electronic bk.)
020 |z019968958X (hbk.)
050 4 QH332|b.V35 2015eb
060 00 2015 E-286
060 10 W 61
072 7 BUS|x008000|2bisacsh
082 04 174.2|223
245 00 Value practices in the life sciences and medicine /
|cedited by Isabelle Dussauge, Claes-Fredrik Helgesson and
250 First edition.
264 1 Oxford, United Kingdom :|bOxford University Press,|c2015.
300 1 online resource
338 online resource|bcr|2rdacarrier
347 text file|2rdaft|0http://rdaregistry.info/termList/
504 Includes bibliographical references and index.
505 0 Cover; Value Practices in the Life Sciences and Medicine;
Copyright; Acknowledgements; Table of Contents; List of
Illustrations; Figures; Tables; List of Contributors; 1:On
the omnipresence, diversity, and elusiveness of values in
the life sciences and medicine; Quod vide value: price
quantity, irreducible, and mystified; What to look for
when looking for values?; Values as enacted; From matters
of concern to stakemaking; How Are Matters of Concerns
Made? Valuation Practices and Stakemaking; What Is Worth
Knowing? Values and the Epistemic; How Much Is It Worth?
Values and the Economic.
505 8 Two precursors of the study of values in the life
sciencesBiocapital: The Enmeshing of Biology and Economy;
Values in the Making of Science: The Moral Economy
Perspective; The rudiments of a ̀value practices approach
: The four themes of this volume; Introducing the Four
Themes of the Volume; Conflicted ̀Public Values; Markets
as Carers for Health; Valuing Human and Non-human Bodies;
Valuations and Knowledge; Part I:Conflicted ̀Public
Values; 2: Key opinion leaders: Valuing independence and
conflictof interest in the medical sciences; KOLs: An
overview; The physician KOL; The researcher KOL.
505 8 Valuing/accepting/denying conflict of interestConclusions;
3: The moral economy of a miracle drug: On exchange
relationships between medicalscience and the
pharmaceutical industryin the 1940s; Consultation;
Procurement; Mediation; Conclusion; Acknowledgements; 4:
The third manuscript: Rules of conduct and the fact-
valuedistinction in mid-twentieth-centurybiochemistry; The
Li affair; Collaboration or competition?; Setting a trap;
Presenting results; Publicity; Indictment and defence; The
plot thickens; The third manuscript; Editorial matters;
Epilogue and discussion; Acknowledgements.
505 8 Part II:Markets as Carers for Health5: A moral economy of
transplantation: Competing regimes of value in the
allocation of transplant organs; Institutionalizing
transplantation and transplant organs; Engineering
fairness in kidney allocation; A thought experiment in
allocation: Livers; Ghosts in the machine: Compassion and
complexity; Discussion: The moral economy of
transplantation; 6: Critical composition of public values:
On the enactment and disarticulationof what counts in
health-care markets; Defining or composing public values-
The case of health-care Markets.
505 8 Market devices for hospital careHow care providers and
insurance companies make markets work; A Health-care
Purchasing Guide as a Valuation Device; The composition of
public values in the Dutch market for hospital care;
Conclusions: Critical composition of value practices;
Acknowledgements; 7: The mosquito multiple: Malaria and
market-based initiatives; The general and the particular;
Market-based interventions in malaria; Malaria and market
devices; Vaccine certainty; Conclusion; Part III:Valuing
Human and Non-human Bodies; 8: Genetic value: The moral
economies of cloning in the zoo.
520 8 Providing a compelling scholarly statement about the
interrelation and pliability of values in the life
sciences, medicine and health care, this volume aims to
aid our understanding of the roles of power, knowledge
production and economic action in the heavily scientised
and economised areas of life science and medicine.
588 0 Vendor-supplied metadata.
650 0 Bioethics.|0http://id.loc.gov/authorities/subjects/
650 0 Medicine|0http://id.loc.gov/authorities/subjects/
650 0 Values.|0http://id.loc.gov/authorities/subjects/sh85141939
650 12 Philosophy, Medical.|0https://id.nlm.nih.gov/mesh/D010686
650 12 Value of Life.|0https://id.nlm.nih.gov/mesh/D026712
650 22 Bioethics.|0https://id.nlm.nih.gov/mesh/D001675
655 0 Electronic book.
655 4 Electronic books.
700 1 Dussauge, Isabelle,|0http://id.loc.gov/authorities/names/
700 1 Helgesson, Claes-Fredrik,|0http://id.loc.gov/authorities/
700 1 Lee, Francis,|d1974-|0http://id.loc.gov/authorities/names/
776 08 |iPrint version :|z9780199689583
990 Oxford University Press|bOxford Scholarship Online
Business and Management|c2019-04-01|yNew collection